Key facts
- It has raised $610K; the latest was Angel (individual) ($600K) in Sep 2025.
- Notable investors include MedTech Innovator, Venture Kick, European Commission, Innosuisse, Horizon Europe — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for MOMM Diagnostics
- ·The full record, as it builds
Funding rounds
No funding rounds for MOMM Diagnostics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MOMM Diagnostics
Operator of a diagnostic platform designed to support early detection of pregnancy-related health conditions. The company focuses on the development of a novel in-vitro diagnostic device for the early diagnosis of preeclampsia (PE) at the point of care, enabling patients to manage maternal and fetal risks more effectively.
- Sector
- Healthcare
- HQ
- Basel, Switzerland
- Founded
- 2018
- Employees
- 5
- Website
- mommdiagnostics.com/
- Ownership
- Privately Held (backing)
MOMM Diagnostics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MOMM Diagnostics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MOMM Diagnostics in its N-PORT filings yet. We sweep new filings monthly.